Continued inhalation of lidocaine suppresses antigen-induced airway hyperreactivity and airway inflammation in ovalbumin-sensitized guinea pigs

International Immunopharmacology

Volumn 8, Issue 5, 2008, Pages 725-731

  Muraki, M ^a   Iwanaga, T ^a   Haraguchi, R ^a   Kubo, H ^a   Tohda, Y ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Bronchial hyperreactivity; Inflammation; Lidocaine; Substance P

Indexed keywords

HISTAMINE; LIDOCAINE; OVALBUMIN; SODIUM CHLORIDE; SUBSTANCE P;

AIRWAY HYPERREACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL; GUINEA PIG; LUNG; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ANESTHETICS, LOCAL; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CAPSAICIN; CELL COUNT; COUGH; EOSINOPHILS; GUINEA PIGS; HISTAMINE; INFLAMMATION; LIDOCAINE; LUNG; MALE; OVALBUMIN; SUBSTANCE P;

EID: 41149152738     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.021     Document Type: Article

References (34)

1. Groeben H., Foster W.M., and Brown R.H. Intravenous lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 154 (1996) 885-888
2. Groeben H., Silvanus M.T., Beste M., and Peters J. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone. Anesthesiology 89 (1998) 862-868
3. Enright P.L., McNally J.F., and Souhrada J.F. Effect of lidocaine on the ventilatory and airway responses to exercise in asthmatics. Am Rev Respir Dis 122 (1980) 823-828
4. Hunt L.W., Swedlund H.A., and Gleich G.J. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin Proc 71 (1996) 361-368
5. Decco M.L., Neeno T.A., Hunt L.W., O'Connell E.J., Yunginger J.W., and Sachs M.I. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study. Ann Allergy Asthma Immun 82 (1999) 29-32
6. Lammers J.W., Minette P., McCusker M.T., Chung K.F., and Barnes P.J. Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo. J Appl Physiol 64 (1988) 1817-1822
7. Fahim M., and Jain S.K. The effect of bupivacaine aerosol on the activity of pulmonary stretch and 'irritant' receptors. J Physiol 288 (1979) 367-378
8. Ohnishi T., Kita H., Mayeno A.N., Okada S., Sur S., Broide D.H., et al. Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil-active cytokines. Clin Exp Immunol 104 (1996) 325-331
9. Okada S., Hagan J.B., Kato M., Bankers-Fulbright J.L., Hunt L.W., Gleich G.J., et al. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 160 (1998) 4010-4017
10. Tanaka A., Minoguchi K., Oda N., Yokoe T., Matsuo H., Okada S., et al. Inhibitory effect of lidocaine on T cells from patients with allergic asthma. J Allergy Clin Immunol 109 (2002) 485-490
11. Hirota K., Hashimoto Y., Sato T., Yoshioka H., Kudo T., Ishihara H., et al. I.v. lidocaine worsens histamine-induced bronchoconstriction in dogs. Br J Anaesth 82 (1999) 87-89
12. Butler J., and Jackson R. Best evidence topic report. Lignocaine as a pretreatment to rapid sequence intubation in patients with status asthmaticus. Emerg Med J 22 (2005) 732
13. Howard P., Cayton R.M., Brennan S.R., and Anderson P.B. Lignocaine aerosol and persistent cough. Br J Dis Chest 71 (1977) 19-24
14. Sheppard D., Rizk N.W., Boushey H.A., and Bethel R.A. Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 127 (1983) 691-694
15. Harrison T.W., and Tattersfield A.E. Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthma. Respir Med 92 (1998) 1359-1363
16. Tohda Y., Muraki M., Iwanaga T., Haraguchi R., Fukuoka M., and Nakajima S. Dual-phase response model for bronchial asthma. Allergy Asthma Proc 21 (2000) 79-84
17. Tohda Y., Muraki M., Kubo H., Itoh M., Haraguchi R., Nakajima S., et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. Respiration 68 (2001) 73-77
18. Muraki M., Tohda Y., Sugihara R., Nagasaka Y., and Nakajima S. The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea-pigs actively sensitized with ovalbumin. J Pharm Pharmacol 46 (1994) 883-886
19. Liu Q., Fujimura M., Tachibana H., Myou S., Kasahara K., and Yasui M. Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin Exp Allergy 31 (2001) 474-484
20. Myou S., Fujimura M., Kurashima K., Kita T., Tachibana H., Ishiura Y., et al. Effects of suplatast tosilate, a new type of anti-allergic agent, on airway cough hypersensitivity induced by airway allergy in guinea-pigs. Clin Exp Allergy 31 (2001) 1939-1944
21. Jolley M.E., Stroupe S.D., Wang C.H., Panas H.N., Keegan C.L., Schmidt R.L., et al. Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem 27 (1981) 1190-1197
22. Wenzel S.E., Szefler S.J., Leung D.Y., Sloan S.I., Rex M.D., and Martin R.J. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156 (1997) 737-743
23. Hunt L.W., Frigas E., Butterfield J.H., Kita H., Blomgren J., Dunnette S.L., et al. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 113 (2004) 853-859
24. Millqvist E. Cough provocation with capsaicin is an objective way to test sensory hyperreactivity in patients with asthma-like symptoms. Allergy 55 (2000) 546-550
25. McCafferty D.M., Sharkey K.A., and Wallace J.L. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 266 (1994) G560-G567
26. Muraki M., Ichihashi H., Yamagata S., Ikeda Y., Kitaguchi S., Santo M., et al. The effect of lidocaine on eosinophil migration. Arerugi 54 (2005) 1113
27. Goetzl E.J., Chernov T., Renold F., and Payan D.G. Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135 (1985) 802s-805s
28. Benyon R.C., Robinson C., and Church M.K. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 97 (1989) 898-904
29. Joos G.F., De Swert K.O., Schelfhout V., and Pauwels R.A. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci 992 (2003) 218-230
30. Tomaki M., Ichinose M., Miura M., Hirayama Y., Yamauchi H., Nakajima N., et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 151 (1995) 613-617
31. Sharara A.M., Higham M.A., Iredale M.J., and Ind P.W. Intradermal actions of hypertonic saline involve neural and vascular mechanisms. Br J Clin Pharmacol 40 (1995) 98-100
32. Nakai S., Iikura Y., Akimoto K., and Shiraki K. Substance p-induced cutaneous and bronchial reactions in children with bronchial asthma. Ann Allergy 66 (1991) 155-161
33. Nieber K., Baumgarten C., Rathsack R., Furkert J., Laake E., Müller S., et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy 23 (1993) 69-71
34. Nieber K., Baumgarten C.R., Rathsack R., Furkert J., Oehme P., and Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 90 (1992) 646-652